Comparison of efficacy of ketamine versus thiopentone-assisted modified electroconvulsive therapy in major depression
- PMID: 31142903
- PMCID: PMC6532456
- DOI: 10.4103/psychiatry.IndianJPsychiatry_386_18
Comparison of efficacy of ketamine versus thiopentone-assisted modified electroconvulsive therapy in major depression
Abstract
Background: It is well known that depression improves faster with electroconvulsive treatment (ECT) than with antidepressant medications. N-methyl-D-aspartate-receptor antagonists (ketamine) have been shown to have rapid antidepressant effects when given as an intravenous infusion. Faster recovery with ECT is likely when used with ketamine as anesthetic.
Aim: The aim of the study is to compare the outcome of modified electroconvulsive therapy (MECT) in major depressive disorder patients undergoing MECT with ketamine versus thiopentone anesthesia.
Materials and methods: Sixty hospitalized patients (age: 18-45 years) with major depressive disorder (Diagnostic and Statistical Manual of Mental Disorders-IV Text Revision) were randomly allocated to either of the two MECT groups (30 patients each) receiving ketamine or thiopentone as anesthetic agent. The participants were assessed on a weekly basis on Hamilton Rating Scale for Depression (HAM-D) and Beck Depression Inventory (BDI).
Results: Ketamine group required significantly lesser number of MECT sessions for achieving remission and had rapid improvement in HAM-D and BDI scores compared to the thiopentone group. Furthermore, the stimulus intensity required to elicit seizures was significantly less and seizure duration was longer in ketamine group compared to the thiopentone group.
Conclusion: The use of ketamine for anesthesia led to rapid recovery from depressive symptoms and seems to be a better option for depressive patients, especially when a rapid response is desired.
Keywords: Depression; electroconvulsive therapy; ketamine; thiopentone.
Conflict of interest statement
There are no conflicts of interest.
Figures
Similar articles
-
Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder.Psychiatry Res. 2014 Feb 28;215(2):355-61. doi: 10.1016/j.psychres.2013.12.008. Epub 2013 Dec 13. Psychiatry Res. 2014. PMID: 24374115 Clinical Trial.
-
Mood and neuropsychological effects of different doses of ketamine in electroconvulsive therapy for treatment-resistant depression.J Affect Disord. 2016 Sep 1;201:124-30. doi: 10.1016/j.jad.2016.05.011. Epub 2016 May 12. J Affect Disord. 2016. PMID: 27208499 Clinical Trial.
-
Comparing effects of ketamine and thiopental administration during electroconvulsive therapy in patients with major depressive disorder: a randomized, double-blind study.J ECT. 2014 Mar;30(1):15-21. doi: 10.1097/YCT.0b013e3182a4b4c6. J ECT. 2014. PMID: 24091902 Clinical Trial.
-
Effects of Ketamine Anesthesia on Efficacy, Tolerability, Seizure Response, and Neurocognitive Outcomes in Electroconvulsive Therapy: A Comprehensive Meta-analysis of Double-Blind Randomized Controlled Trials.J ECT. 2020 Jun;36(2):94-105. doi: 10.1097/YCT.0000000000000632. J ECT. 2020. PMID: 31725054
-
Ketamine Augmentation of Electroconvulsive Therapy: A Scoping Review of Dose-Dependent Effects in Major Depressive Disorder.Cureus. 2023 Jun 7;15(6):e40087. doi: 10.7759/cureus.40087. eCollection 2023 Jun. Cureus. 2023. PMID: 37292107 Free PMC article.
Cited by
-
Topiramate and other kainate receptor antagonists for depression: A systematic review of randomized controlled trials.Neuropsychopharmacol Rep. 2022 Dec;42(4):421-429. doi: 10.1002/npr2.12284. Epub 2022 Aug 1. Neuropsychopharmacol Rep. 2022. PMID: 35912516 Free PMC article.
-
Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder.Cochrane Database Syst Rev. 2021 Sep 12;9(9):CD011612. doi: 10.1002/14651858.CD011612.pub3. Cochrane Database Syst Rev. 2021. PMID: 34510411 Free PMC article.
-
Low-dose ketamine does not improve the speed of recovery from depression in electroconvulsive therapy: a randomized controlled trial.Braz J Psychiatry. 2022 Jan-Feb;44(1):6-14. doi: 10.1590/1516-4446-2020-1705. Braz J Psychiatry. 2022. PMID: 34076068 Free PMC article. Clinical Trial.
-
Comparison of efficacy of ketamine versus thiopentone-assisted modified electroconvulsive therapy in major depression.Indian J Psychiatry. 2020 Jul-Aug;62(4):442-443. doi: 10.4103/psychiatry.IndianJPsychiatry_518_19. Epub 2020 Jul 27. Indian J Psychiatry. 2020. PMID: 33165361 Free PMC article. No abstract available.
References
-
- Rihmer Z, Merikangas KR. Mood disorders: Epidemiology. In: Sadock VA, Sadock BJ, Ruiz P, editors. Kaplan and Sadock's Comprehensive Textbook of Psychiatry. 10th ed. Vol. 1. Philadelphia, PA: Williams & Wilkins; 2017. p. 1614.
-
- Jick H, Kaye JA, Jick SS. Antidepressants and the risk of suicidal behaviors. JAMA. 2004;292:338–43. - PubMed
-
- Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry. 2000;47:351–4. - PubMed
-
- Zarate CA, Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry. 2006;63:856–64. - PubMed